
Charvi Kalal
PharmD
Charvi Kalal is a Pharm.D intern and aspiring medical writer with hands-on experience in medical writing, clinical research, pharmacovigilance, and clinical pharmacy. She has experience in medical content writing through CliMed, along with exposure to ADR monitoring, prescription analysis, patient counselling, literature review, and research documentation. Her research focuses on ADR monitoring and reporting in breast cancer patients receiving targeted therapy. With certifications in GCP, biomedical research, scientific writing, and clinical research, she is passionate about transforming scientific evidence into accurate, engaging, and accessible healthcare content.
About Charvi
Charvi Kalal (PharmD) is a writer at Pharmacally, with 44 published articles, each checked against primary sources by our editorial team.
Articles by Charvi Kalal
Clinical TrialsBioCryst Reports Reduced Healthcare Utilization Across ORLADEYO Studies
Health TidingsJohnson & Johnson Reports Second Phase 3 Success for CAPLYTA
Clinical TrialsUCB and Biogen Report Positive Lupus Findings for Dapirolizumab
Clinical TrialsGilead Reports 75.4% ALP Normalization With Livdelzi in IDEAL Trial
Clinical TrialsIksuda Reports 53% Response Rate for IKS03 in B-Cell Lymphoma
Clinical TrialsMerck Advances Ohtuvayre into Phase 3 COPD Exacerbation Trial
Clinical TrialsInventisBio’s D-2570 Delivers Up to 90% PASI 75 Response in Psoriasis Trial
Clinical TrialsAcumen Reports Sabirnetug Failure Despite Amyloid Reduction
Clinical TrialsOno Advances ONO-1110 Despite Failed Pain Trial Endpoints
A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala